Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 238, Issue 2, Pages 306-328Publisher
WILEY
DOI: 10.1002/jcp.30931
Keywords
cancer; embryogenesis; neural crest; neuroblastoma; Wnt; beta-catenin
Categories
Ask authors/readers for more resources
Neuroblastoma is a common heterogeneous extracranial cancer in infancy that is associated with aberrant activation of the Wnt signaling pathway. The Wnt signaling pathway regulates the development and differentiation of neural crest cells and affects the proliferation and metastasis of neuroblastoma. Inhibiting the Wnt signaling pathway can induce apoptosis and prevent the occurrence of neuroblastoma.
Neuroblastoma (NB) is one of the most common heterogeneous extracranial cancers in infancy that arises from neural crest (NC) cells of the sympathetic nervous system. The Wnt signaling pathway, both canonical and noncanonical pathway, is a highly conserved signaling pathway that regulates the development and differentiation of the NC cells during embryogenesis. Reports suggest that aberrant activation of Wnt ligands/receptors in Wnt signaling pathways promote progression and relapse of NB. Wnt signaling pathways regulate NC induction and migration in a similar manner; it regulates proliferation and metastasis of NB. Inhibiting the Wnt signaling pathway or its ligands/receptors induces apoptosis and abrogates proliferation and tumorigenicity in all major types of NB cells. Here, we comprehensively discuss the Wnt signaling pathway and its mechanisms in regulating the development of NC and NB pathogenesis. This review highlights the implications of aberrant Wnt signaling in the context of etiology, progression, and relapse of NB. We have also described emerging strategies for Wnt-based therapies against the progression of NB that will provide new insights into the development of Wnt-based therapeutic strategies for NB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available